Angie Craig actually said...

One study found that if Medicare is able to negotiate, lower drug prices and cost-sharing responsibilities for beneficiaries are reduced.

The burden of high out-of-pocket costs of drugs on Medicare beneficiaries is significant.

Long COVID is such a complex disease that we don't know so much about it at this point.

I urge all Committee Members to read the full report.